SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three and nine months ended September 30, 2024, and 2023, and their accounts receivable balance as of September 30, 2024:

	Sales % Three Months Ended September 30, 2024			Sales % Nine Months Ended September 30, 2024			Sales % Three Months Ended September 30, 2023			Sales % Nine Months Ended September 30, 2023			Accounts receivable balance September 30, 2024
Customer A		32.6	%		N/A			82.5	%		92.6	%	$	-
Customer B		N/A			67.9	%		N/A			N/A		$	-
Customer C		16.4	%		18.7	%		N/A			N/A		$	-
Customer D		23.6	%		N/A			N/A			N/A		$	17,500
Customer E		10.1	%		N/A			N/A			N/A		$	10,500

SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS

Building	10-25 years
Office furniture and equipment	3-5 years
Warehouse equipment	7 years

SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates our revenue by major source for the three and nine months ended September 30, 2024, and 2023:

	Three months ended September 30,				Nine months ended September 30,
	2024		2023		2024		2023
Sourced and distributed products	$	51,104	$	155,009	$	1,005,878	$	4,127,633
OED Installations		23,182		17,550		262,102		77,450
Total	$	74,286	$	172,559	$	1,267,980	$	4,205,083

SCHEDULE OF DERIVATIVE INSTRUMENTS

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of September 30, 2024, and December 31, 2023, for each fair value hierarchy level:

September 30, 2024	Derivative Liabilities		Total
Level I	$	-	$	-
Level II	$	-	$	-
Level III	$	666,677	$	666,677

December 31, 2023	Derivative Liabilities		Total
Level I	$	-	$	-
Level II	$	-	$	-
Level III	$	1,216,078	$	1,216,078

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

	September 30, 2024		September 30, 2023
Convertible preferred stock (1)		10,021,982,759		7,586,559,420
Unexercised common stock purchase warrants (1)		807,024,518		1,047,024,518
Convertible notes payable (1)		68,791,734		20,535,748
Promissory notes payable (1)		712,746,575		186,369,863
		11,610,545,586		8,840,489,549

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.